|

Artificial Intelligence Scalable Solution for ST Myocardial Infarction

RECRUITINGSponsored by Idoven 1903 S.L.
Actively Recruiting
SponsorIdoven 1903 S.L.
Started2025-04-01
Est. completion2026-03
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06939738

Summary

The ASSIST clinical study is an observational, multicenter study to assess the performance of a cloud-based and AI-powered electrocardiogram (ECG) analysis platform, named Willem™, developed to detect Acute Myocardial Infarction (AMI). The main objectives are to compare Willem™ performance to detect and triage ECG patterns associated with AMI compared with human ECG interpretation, and to assess the time periods for both approaches.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age ≥ 18 years;
* Available digitally stored 12-lead ECG traces prior to invasive coronary angiography;
* Available angiographic and clinical data.

Exclusion Criteria:

* ECGs with poor signal quality;
* Lack of digitally stored 12-lead ECG traces prior to coronary angiography;
* Previous coronary events (AMI, coronary revascularizations);
* Non-available clinical or angiographic data.

Conditions2

Acute Myocardial Infarction (AMI)Heart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.